COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies
Afagh Garjani, Rod Middleton, Rachael Hunter, Katherine Tuite-Dalton, Alasdair Coles, Ruth Dobson, Martin Duddy, Stella Hughes, Owen Pearson, David Rog, Emma Tallantyre, Roshan das Nair, Richard Nicholas, Nikos Evangelou
Topics & Concepts
MedicineMultiple sclerosisExacerbationCoronavirus disease 2019 (COVID-19)Internal medicineDiseaseCohortExpanded Disability Status ScaleProspective cohort studyPediatricsImmunologyInfectious disease (medical specialty)Multiple Sclerosis Research StudiesLong-Term Effects of COVID-19Peripheral Neuropathies and Disorders